Cargando…
Prevalence of Anti-deamidated Gliadin Peptide Antibodies in Asian Patients With Irritable Bowel Syndrome
BACKGROUND/AIMS: Non-celiac gluten sensitivity has been increasingly recognized as a predisposing factor for irritable bowel syndrome (IBS)-like symptoms in Western populations where celiac disease (CD) is relatively common. In Asia where CD is rare, we wish to determine the prevalence of gluten pro...
Autores principales: | Lu, Wei, Gwee, Kok-Ann, Siah, Kewin Tien Ho, Kang, Jin Yong, Lee, Rumin, Ngan, Cecilia Cheng Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015193/ https://www.ncbi.nlm.nih.gov/pubmed/24840376 http://dx.doi.org/10.5056/jnm.2014.20.2.236 |
Ejemplares similares
-
Prevalence of Irritable Bowel Syndrome in Singapore and Its Association with Dietary, Lifestyle, and Environmental Factors
por: Siah, Kewin T H, et al.
Publicado: (2016) -
Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!
por: Arigliani, Michele, et al.
Publicado: (2017) -
Allergenicity of Deamidated and/or Peptide-Bond-Hydrolyzed Wheat Gliadin by Transdermal Administration
por: Abe, Ryosuke, et al.
Publicado: (2020) -
Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease
por: de Chaisemartin, Luc, et al.
Publicado: (2015) -
Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease
por: Diós, Ádám, et al.
Publicado: (2022)